Literature DB >> 32814978

Post-COVID-19 pneumonia pulmonary fibrosis.

S Tale1, S Ghosh2, S P Meitei3, M Kolli4, A K Garbhapu5, S Pudi6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32814978      PMCID: PMC7454835          DOI: 10.1093/qjmed/hcaa255

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.
  22 in total

1.  In fatal COVID-19, the immune response can control the virus but kill the patient.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-11       Impact factor: 11.205

Review 2.  Sports Imaging of COVID-19: A Multi-Organ System Review of Indications and Imaging Findings.

Authors:  Ali Rashidi; Jan Fritz
Journal:  Sports Health       Date:  2022-06-23       Impact factor: 4.355

3.  Research on the mechanism of berberine in the treatment of COVID-19 pneumonia pulmonary fibrosis using network pharmacology and molecular docking.

Authors:  Junfeng Cao; Lianglei Li; Li Xiong; Chaochao Wang; Yijun Chen; Xiao Zhang
Journal:  Phytomed Plus       Date:  2022-03-04

4.  Dual inhibition of CB1 receptors and iNOS, as a potential novel approach to the pharmacological management of acute and long COVID-19.

Authors:  Resat Cinar; Malliga R Iyer; George Kunos
Journal:  Br J Pharmacol       Date:  2021-04-17       Impact factor: 9.473

5.  The second wave of desaturation in coronavirus disease 2019.

Authors:  M I Alghizzawi; F Ata; Z Yousaf; M A Alhiyari; A Bint I Bilal; A Elhiday; A S Abdulhadi
Journal:  New Microbes New Infect       Date:  2021-03-19

6.  Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection.

Authors:  Mousa Ahmad Alhiyari; Fateen Ata; Mohd Islam Alghizzawi; Ammara Bint I Bilal; Ahmad Salih Abdulhadi; Zohaib Yousaf
Journal:  IDCases       Date:  2020-12-31

7.  Pulmonary Fibrosis After COVID-19 Pneumonia.

Authors:  Bilal Malik; Basel Abdelazeem; Abhijeet Ghatol
Journal:  Cureus       Date:  2021-03-16

8.  Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.

Authors:  Mingshan Xue; Teng Zhang; Hao Chen; Yifeng Zeng; Runpei Lin; Yingjie Zhen; Ning Li; Zhifeng Huang; Haisheng Hu; Luqian Zhou; Hui Wang; Xiaohua Douglas Zhang; Baoqing Sun
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580

Review 9.  Post-COVID Syndrome: An Insight on Its Pathogenesis.

Authors:  Helena C Maltezou; Androula Pavli; Athanasios Tsakris
Journal:  Vaccines (Basel)       Date:  2021-05-12

10.  Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?

Authors:  Elia Bari; Ilaria Ferrarotti; Laura Saracino; Sara Perteghella; Maria Luisa Torre; Luca Richeldi; Angelo Guido Corsico
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.